Source: Annual Congress 2006 - Miscellaneous bronchial and other respiratory disorders in children
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Paraskakis, E. Galanakis, H. Vergadi, S. Maraki, A. Georgiladakis, M. Kalmanti (Heraklion, Greece). Risk factors for MRSA staphylococcal carriage in children with chronic allergic diseases. Eur Respir J 2006; 28: Suppl. 50, 1536

Member's Comments

No comment yet.

Related content which might interest you: Incidence and risk factors of MRSA pneumonia Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Risk factors of community-acquired pneumonia in children Source: Eur Respir J 2010; 36: 1221-1222 Year: 2010 Chlamydia pneumoniae in children with chronic and recurrent bronchopulmonary diseases Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006 Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Risk factors of paediatric community-acquired pneumonia Source: Eur Respir J 2011; 37: 724-725 Year: 2011 Risk factors for infections with potentially resistant pathogens in patients in a pneumological intensive-care-unit Source: Eur Respir J 2002; 20: Suppl. 38, 476s Year: 2002 Pulmonary disease as a risk factor for community-acquired pneumonia caused by multiple pathogens, including Streptococcus pneumoniae Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001 The impact of sensitization to Staphylococcus aureus–derived enterotoxins on allergic and respiratory disorders Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Risk factors for early onset severe community-acquired pneumonia complications Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Moulds and Staphylococcus aureus enterotoxins are relevant allergens to affect Type 2 inflammation and clinical outcomes in chronic rhinosinusitis patients Source: ERJ Open Res, 6 (4) 00265-2020; 10.1183/23120541.00265-2020 Year: 2020 Risk factors of frequent exacerbations in difficult-to-treat asthma Source: Eur Respir J 2006; 27: 1324-1325 Year: 2006 Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Spread of carriage of pneumonia and acute respiratory diseases (ARS) agents in recruits Source: Eur Respir J 2005; 26: Suppl. 49, 144s Year: 2005 Risk factors of nosocomial pneumonia in multiple trauma patients Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017 Year: 2018 Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia Source: Eur Respir J 2009; 34: 1148-1158 Year: 2009 Antibiotics and new guidelines for the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175 Year: 2004 Population prevalence and risk factors for chronic bronchitis in India Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005